High Levels of Treatment Success and Zero Relapse in Multidrug-Resistant Tuberculosis Patients Receiving a Levofloxacin-Based Shorter Treatment Regimen in Vietnam

Vietnam has been using a levofloxacin-based shorter treatment regimen (STR) for rifampicin resistant/multidrug-resistant tuberculosis (RR/MDR-TB) patients since 2016 on a pilot basis. This regimen lasts for 9–11 months and is provided to RR/MDR-TB patients without second-line drug resistance. We rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Anh, Le T. N., M. V. Kumar, Ajay, Ramaswamy, Gomathi, Htun, Thurain, Thanh Hoang Thi, Thuy, Hoai Nguyen, Giang, Quelapio, Mamel, Gebhard, Agnes, Nguyen, Hoa Binh, Nguyen, Nhung Viet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157716/
https://www.ncbi.nlm.nih.gov/pubmed/32164231
http://dx.doi.org/10.3390/tropicalmed5010043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157716/
https://www.ncbi.nlm.nih.gov/pubmed/32164231
http://dx.doi.org/10.3390/tropicalmed5010043

Ejemplares similares